Check out the companies making headlines in midday trading: Meta Platforms — Shares of the Facebook parent jumped about 4% after the company beat earnings expectations . Meta signaled ongoing advertising resilience and upped its capital expenditures range to reflect more data center infrastructure investments, even amid macroeconomic uncertainty. The company also issued in-line guidance for the current period. Wayfair — The online home goods store gained nearly 2% after first-quarter results beat Wall Street’s estimates on the top and bottom lines. Wayfair notched an adjusted 10 cents per share on revenue of $2.73 billion, while analysts polled by LSEG forecast a loss of 22 cents per share on $2.71 billion of revenue. Wayfair also reported improvement in its gross profit and free cash flow metrics. Align Technology — The dental products company added more than 2% after first-quarter earnings topped expectations. Align reported $2.13 in adjusted earnings per share, above the $1.99 per share projected by analysts, according to FactSet. The company also said the clear aligner products it sells in the U.S. are made in Mexico, not China, potentially limiting the effect of tariffs. Tesla — The stock moved nearly 1% higher after Tesla shot down a report in The Wall Street Journal that the electric vehicle maker’s board was searching for a replacement for CEO Elon Musk. Qualcomm — The chipmaker fell almost 8% after forecasting revenue for its current quarter that was slightly below expectations . However, Qualcomm beat forecasts for both its fiscal second-quarter earnings and revenue, while its chip sales also showed strong year-over-year growth. Microsoft — The tech giant added 8% after surpassing Wall Street’s expectations on the top and bottom lines in the fiscal third quarter. Microsoft also issued rosy guidance for the full year. CVS Health — The pharmacy stock gained almost 6% following first-quarter results . CVS reported adjusted earnings per share of $2.25 on revenue of $94.59 billion in the first quarter, while analysts surveyed by LSEG were looking for $1.70 in earnings per share and $93.64 billion in revenue. The company also upped its earnings outlook for the full year. Amazon — Shares climbed nearly 3% following news that the e-commerce giant plans to spend $4 billion by the end of 2026 to expand its small-town delivery network in the rural U.S. Eli Lilly — The pharmaceutical stock pulled back 10% after Eli Lilly slashed its full-year profit outlook, citing charges tied to a cancer treatment deal. First-quarter revenue and earnings surpassed analysts’ estimates, driven by rising demand for both weight loss and diabetes drugs. The firm expects full-year earnings in the range of $20.78 to $22.28 per share, compared to its prior forecast that called for $22.50 to $24 per share. Organon & Co. — Shares of the pharmaceutical company plummeted 26% after Organon slashed its quarterly dividend to 2 cents per share, down from 28 cents per share. The company said it was aiming to strengthen its capital structure and speed up the process toward deleveraging. Becton, Dickinson and Company — The medical device manufacturer slumped about 15%. Becton, Dickinson and Company surpassed analysts’ estimates on the top and bottom lines in the second quarter, but the company lowered its adjusted earnings per share outlook for the full year to reflect the effect of tariffs. The company now sees adjusted earnings coming in between $14.06 and $14.34 per share, compared to its earlier call for between $14.30 and $14.60 per share. Quanta Services — The construction engineering company surged about 11% after posting beats on the top and bottom lines in the first quarter. Quanta posted adjusted earnings of $1.78 per share on revenue of $6.23 billion. The result surpassed analysts’ call for $1.67 in earnings per share and $5.86 billion in revenue, per FactSet. Carrier Global — The manufacturer of heating and cooling products jumped 11% after hiking its full-year guidance. Carrier sees adjusted earnings ranging between $3 and $3.10 per share, up from its earlier guidance of between $2.95 and $3.05 per share. The result is also ahead of the FactSet consensus estimate of $2.98 per share. — CNBC’s Lisa Kailai Han, Pia Singh, Michelle Fox, Jesse Pound and Darla Mercado contributed reporting.